GSK Annual Net Income
$6.13 B
-$12.39 B-66.89%
31 December 2023
Summary:
As of January 22, 2025, GSK annual net profit is $6.13 billion, with the most recent change of -$12.39 billion (-66.89%) on December 31, 2023. During the last 3 years, it has fallen by -$1.25 billion (-16.89%). GSK annual net income is now -66.89% below its all-time high of $18.52 billion, reached on December 31, 2022.GSK Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GSK Quarterly Net Income
-$75.47 M
-$1.56 B-105.10%
30 September 2024
Summary:
As of January 22, 2025, GSK quarterly net profit is -$75.47 million, with the most recent change of -$1.56 billion (-105.10%) on September 30, 2024. Over the past year, it has dropped by -$510.16 million (-117.36%). GSK quarterly net income is now -100.59% below its all-time high of $12.74 billion, reached on September 30, 2022.GSK Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GSK TTM Net Income
$3.17 B
-$1.93 B-37.86%
30 September 2024
Summary:
As of January 22, 2025, GSK TTM net profit is $3.17 billion, with the most recent change of -$1.93 billion (-37.86%) on September 30, 2024. Over the past year, it has dropped by -$2.97 billion (-48.37%). GSK TTM net income is now -82.73% below its all-time high of $18.34 billion, reached on June 30, 2023.GSK TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GSK Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -66.9% | -117.4% | -48.4% |
| 3 y3 years | -16.9% | -103.1% | -51.7% |
| 5 y5 years | +26.9% | -103.1% | -51.7% |
GSK Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -66.9% | +1.6% | -100.6% | at low | -82.7% | at low |
| 5 y | 5-year | -66.9% | +3.4% | -100.6% | at low | -82.7% | at low |
| alltime | all time | -66.9% | +964.4% | -100.6% | +93.1% | -82.7% | +4090.8% |
GSK Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$75.47 M(-105.1%) | $3.17 B(-37.9%) |
| June 2024 | - | $1.48 B(+11.5%) | $5.10 B(-9.8%) |
| Mar 2024 | - | $1.33 B(+205.2%) | $5.65 B(-7.9%) |
| Dec 2023 | $6.13 B(-66.9%) | $434.69 M(-76.6%) | $6.13 B(-17.7%) |
| Sept 2023 | - | $1.85 B(-8.8%) | $7.46 B(-59.3%) |
| June 2023 | - | $2.03 B(+12.2%) | $18.34 B(+5.6%) |
| Mar 2023 | - | $1.81 B(+3.0%) | $17.36 B(-3.4%) |
| Dec 2022 | $18.52 B(+207.0%) | $1.76 B(-86.2%) | $17.96 B(+8.9%) |
| Sept 2022 | - | $12.74 B(+1108.9%) | $16.50 B(+191.9%) |
| June 2022 | - | $1.05 B(-56.4%) | $5.65 B(-13.7%) |
| Mar 2022 | - | $2.42 B(+718.9%) | $6.55 B(+16.7%) |
| Dec 2021 | $6.03 B(-18.2%) | $295.22 M(-84.3%) | $5.61 B(-9.6%) |
| Sept 2021 | - | $1.89 B(-3.3%) | $6.21 B(+4.7%) |
| June 2021 | - | $1.95 B(+31.8%) | $5.93 B(-12.6%) |
| Mar 2021 | - | $1.48 B(+65.6%) | $6.79 B(-7.2%) |
| Dec 2020 | $7.38 B(+24.4%) | $893.26 M(-44.4%) | $7.31 B(-9.6%) |
| Sept 2020 | - | $1.61 B(-42.7%) | $8.09 B(-3.6%) |
| June 2020 | - | $2.81 B(+39.9%) | $8.40 B(+22.9%) |
| Mar 2020 | - | $2.01 B(+19.9%) | $6.83 B(+15.7%) |
| Dec 2019 | $5.93 B(+22.7%) | $1.67 B(-12.5%) | $5.91 B(+1.9%) |
| Sept 2019 | - | $1.91 B(+54.4%) | $5.80 B(+1.1%) |
| June 2019 | - | $1.24 B(+14.6%) | $5.73 B(+12.5%) |
| Mar 2019 | - | $1.08 B(-30.8%) | $5.09 B(+6.7%) |
| Dec 2018 | $4.83 B(+144.4%) | $1.56 B(-15.4%) | $4.77 B(+92.0%) |
| Sept 2018 | - | $1.85 B(+207.4%) | $2.49 B(+11.7%) |
| June 2018 | - | $600.96 M(-21.3%) | $2.23 B(+59.6%) |
| Mar 2018 | - | $763.39 M(-205.3%) | $1.39 B(-27.6%) |
| Dec 2017 | $1.98 B(+60.1%) | -$725.04 M(-145.7%) | $1.93 B(-35.1%) |
| Sept 2017 | - | $1.59 B(-789.5%) | $2.97 B(+21.5%) |
| June 2017 | - | -$230.10 M(-117.8%) | $2.45 B(+19.2%) |
| Mar 2017 | - | $1.30 B(+305.8%) | $2.05 B(+76.9%) |
| Dec 2016 | $1.24 B(-90.4%) | $319.24 M(-69.9%) | $1.16 B(+282.4%) |
| Sept 2016 | - | $1.06 B(-269.9%) | $303.21 M(+301.4%) |
| June 2016 | - | -$624.85 M(-254.8%) | $75.54 M(-91.9%) |
| Mar 2016 | - | $403.69 M(-175.2%) | $928.63 M(-92.7%) |
| Dec 2015 | $12.87 B(+183.3%) | -$536.96 M(-164.4%) | $12.79 B(-14.5%) |
| Sept 2015 | - | $833.66 M(+265.3%) | $14.96 B(+1.1%) |
| June 2015 | - | $228.23 M(-98.1%) | $14.79 B(-5.6%) |
| Mar 2015 | - | $12.26 B(+650.3%) | $15.67 B(+247.4%) |
| Dec 2014 | $4.54 B(-46.6%) | $1.63 B(+144.1%) | $4.51 B(-34.3%) |
| Sept 2014 | - | $669.49 M(-39.2%) | $6.86 B(-10.8%) |
| June 2014 | - | $1.10 B(-0.4%) | $7.69 B(-6.2%) |
| Mar 2014 | - | $1.11 B(-72.3%) | $8.20 B(-4.5%) |
| Dec 2013 | $8.51 B(+19.3%) | $3.98 B(+165.1%) | $8.58 B(+44.0%) |
| Sept 2013 | - | $1.50 B(-6.4%) | $5.96 B(-3.9%) |
| June 2013 | - | $1.61 B(+7.5%) | $6.20 B(-5.4%) |
| Mar 2013 | - | $1.49 B(+9.7%) | $6.56 B(-7.9%) |
| Dec 2012 | $7.13 B(-15.5%) | $1.36 B(-22.0%) | $7.12 B(-7.8%) |
| Sept 2012 | - | $1.74 B(-11.0%) | $7.73 B(-5.8%) |
| June 2012 | - | $1.96 B(-4.6%) | $8.20 B(+1.9%) |
| Mar 2012 | - | $2.05 B(+4.4%) | $8.05 B(-4.6%) |
| Dec 2011 | $8.44 B(+234.9%) | $1.97 B(-11.3%) | $8.43 B(+56.9%) |
| Sept 2011 | - | $2.22 B(+23.0%) | $5.38 B(+4.3%) |
| June 2011 | - | $1.80 B(-26.1%) | $5.15 B(+78.0%) |
| Mar 2011 | - | $2.44 B(-324.1%) | $2.90 B(+13.9%) |
| Dec 2010 | $2.52 B(-70.9%) | -$1.09 B(-154.6%) | $2.54 B(-59.6%) |
| Sept 2010 | - | $2.00 B(-540.3%) | $6.29 B(-3.0%) |
| June 2010 | - | -$453.16 M(-121.7%) | $6.49 B(-29.2%) |
| Mar 2010 | - | $2.09 B(-21.5%) | $9.17 B(+5.3%) |
| Dec 2009 | $8.66 B(+1.8%) | $2.66 B(+21.6%) | $8.71 B(+14.9%) |
| Sept 2009 | - | $2.19 B(-1.8%) | $7.58 B(+3.4%) |
| June 2009 | - | $2.23 B(+37.2%) | $7.33 B(-4.0%) |
| Mar 2009 | - | $1.63 B(+5.8%) | $7.64 B(-11.2%) |
| Dec 2008 | $8.51 B(-18.5%) | $1.54 B(-20.9%) | $8.60 B(-6.9%) |
| Sept 2008 | - | $1.94 B(-23.4%) | $9.23 B(-7.1%) |
| June 2008 | - | $2.54 B(-1.9%) | $9.94 B(-1.1%) |
| Mar 2008 | - | $2.58 B(+19.0%) | $10.05 B(-3.6%) |
| Dec 2007 | $10.45 B(+5.2%) | $2.17 B(-18.0%) | $10.43 B(-0.8%) |
| Sept 2007 | - | $2.65 B(+0.0%) | $10.52 B(+0.4%) |
| June 2007 | - | $2.65 B(-10.6%) | $10.47 B(+2.4%) |
| Mar 2007 | - | $2.96 B(+30.9%) | $10.23 B(+3.3%) |
| Dec 2006 | $9.93 B(+16.5%) | $2.26 B(-13.2%) | $9.90 B(+3.2%) |
| Sept 2006 | - | $2.61 B(+8.3%) | $9.60 B(+5.9%) |
| June 2006 | - | $2.41 B(-8.5%) | $9.06 B(+2.3%) |
| Mar 2006 | - | $2.63 B(+34.3%) | $8.86 B(+4.2%) |
| Dec 2005 | $8.53 B(+19.1%) | $1.96 B(-5.3%) | $8.50 B(+6.5%) |
| Sept 2005 | - | $2.07 B(-6.1%) | $7.99 B(+3.0%) |
| June 2005 | - | $2.20 B(-3.1%) | $7.75 B(+3.1%) |
| Mar 2005 | - | $2.27 B(+57.8%) | $7.52 B(+5.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2004 | $7.16 B(-2.2%) | $1.44 B(-21.5%) | $7.15 B(+1.5%) |
| Sept 2004 | - | $1.84 B(-6.7%) | $7.04 B(-0.5%) |
| June 2004 | - | $1.97 B(+3.3%) | $7.08 B(-2.4%) |
| Mar 2004 | - | $1.91 B(+42.5%) | $7.26 B(-0.5%) |
| Dec 2003 | $7.32 B(+23.8%) | $1.34 B(-28.7%) | $7.29 B(-1.9%) |
| Sept 2003 | - | $1.87 B(-12.4%) | $7.43 B(+9.6%) |
| June 2003 | - | $2.14 B(+10.3%) | $6.78 B(+6.5%) |
| Mar 2003 | - | $1.94 B(+31.4%) | $6.37 B(+8.1%) |
| Dec 2002 | $5.91 B(+32.5%) | $1.48 B(+20.7%) | $5.89 B(+0.7%) |
| Sept 2002 | - | $1.22 B(-29.0%) | $5.85 B(+13.2%) |
| June 2002 | - | $1.72 B(+17.8%) | $5.17 B(+5.4%) |
| Mar 2002 | - | $1.46 B(+2.0%) | $4.90 B(+9.9%) |
| Dec 2001 | $4.46 B(-29.2%) | $1.43 B(+163.9%) | $4.46 B(-19.6%) |
| Sept 2001 | - | $543.60 M(-62.8%) | $5.55 B(-9.2%) |
| June 2001 | - | $1.46 B(+42.8%) | $6.11 B(+1.9%) |
| Mar 2001 | - | $1.02 B(-59.5%) | $6.00 B(-4.0%) |
| Dec 2000 | $6.31 B(+115.3%) | $2.52 B(+128.0%) | $6.25 B(+39.6%) |
| Sept 2000 | - | $1.11 B(-17.9%) | $4.47 B(+9.0%) |
| June 2000 | - | $1.35 B(+5.7%) | $4.10 B(+16.4%) |
| Mar 2000 | - | $1.27 B(+70.1%) | $3.53 B(+17.6%) |
| Dec 1999 | $2.93 B(-3.7%) | $748.61 M(+1.9%) | $3.00 B(-3.2%) |
| Sept 1999 | - | $734.58 M(-4.5%) | $3.10 B(-3.1%) |
| June 1999 | - | $769.18 M(+3.1%) | $3.20 B(+2.8%) |
| Mar 1999 | - | $746.03 M(-12.0%) | $3.11 B(+2.2%) |
| Dec 1998 | $3.04 B(+0.4%) | $847.33 M(+1.7%) | $3.04 B(+7.6%) |
| Sept 1998 | - | $833.17 M(+21.9%) | $2.83 B(+5.8%) |
| June 1998 | - | $683.47 M(+0.5%) | $2.67 B(-5.4%) |
| Mar 1998 | - | $680.26 M(+7.8%) | $2.83 B(-5.6%) |
| Dec 1997 | $3.03 B(-2.8%) | $631.02 M(-7.1%) | $3.00 B(-20.1%) |
| Sept 1997 | - | $678.89 M(-18.9%) | $3.75 B(+15.3%) |
| June 1997 | - | $836.67 M(-1.4%) | $3.25 B(+1.3%) |
| Mar 1997 | - | $848.90 M(-38.8%) | $3.21 B(+1.2%) |
| Dec 1996 | $3.12 B(+35.5%) | $1.39 B(+664.6%) | $3.17 B(+77.5%) |
| Sept 1996 | - | $181.27 M(-77.2%) | $1.79 B(-11.4%) |
| June 1996 | - | $794.63 M(-2.1%) | $2.02 B(+21.9%) |
| Mar 1996 | - | $811.76 M(+97.4%) | $1.65 B(-0.8%) |
| Dec 1995 | $2.30 B(+40.3%) | - | - |
| Sept 1995 | - | $411.31 M(-4.8%) | $1.67 B(+0.3%) |
| June 1995 | - | $431.87 M(+6.5%) | $1.66 B(+2.0%) |
| June 1995 | $1.64 B(-15.6%) | - | - |
| Mar 1995 | - | $405.61 M(-3.3%) | $1.63 B(-3.9%) |
| Dec 1994 | - | $419.37 M(+3.3%) | $1.70 B(-6.5%) |
| Sept 1994 | - | $405.93 M(+1.7%) | $1.81 B(-6.5%) |
| June 1994 | $1.94 B(-0.9%) | $399.24 M(-15.4%) | $1.94 B(+0.4%) |
| Mar 1994 | - | $471.74 M(-12.3%) | $1.93 B(-2.8%) |
| Dec 1993 | - | $537.98 M(+1.3%) | $1.99 B(+4.0%) |
| Sept 1993 | - | $531.29 M(+35.4%) | $1.91 B(+3.0%) |
| June 1993 | $1.96 B(+8.0%) | $392.26 M(-25.6%) | $1.86 B(+3.1%) |
| Mar 1993 | - | $526.93 M(+14.0%) | $1.80 B(+1.5%) |
| Dec 1992 | - | $462.18 M(-2.9%) | $1.77 B(-0.2%) |
| Sept 1992 | - | $475.77 M(+41.8%) | $1.78 B(+0.2%) |
| June 1992 | $1.82 B(+11.2%) | $335.55 M(-32.9%) | $1.77 B(-7.9%) |
| Mar 1992 | - | $499.82 M(+7.2%) | $1.93 B(+5.1%) |
| Dec 1991 | - | $466.37 M(-1.3%) | $1.83 B(+5.3%) |
| Sept 1991 | - | $472.50 M(-3.0%) | $1.74 B(+6.4%) |
| June 1991 | $1.63 B(+24.5%) | $487.06 M(+19.9%) | $1.63 B(+10.3%) |
| Mar 1991 | - | $406.21 M(+8.7%) | $1.48 B(+3.0%) |
| Dec 1990 | - | $373.54 M(+1.5%) | $1.44 B(+3.2%) |
| Sept 1990 | - | $367.88 M(+9.8%) | $1.40 B(+3.0%) |
| June 1990 | $1.31 B(+11.2%) | $334.99 M(-7.8%) | $1.35 B(+0.2%) |
| Mar 1990 | - | $363.21 M(+10.4%) | $1.35 B(+8.6%) |
| Dec 1989 | - | $328.94 M(+0.5%) | $1.25 B(+3.7%) |
| Sept 1989 | - | $327.45 M(-1.5%) | $1.20 B(+3.4%) |
| June 1989 | $1.18 B(+15.9%) | $332.29 M(+29.5%) | $1.16 B(+0.5%) |
| Mar 1989 | - | $256.54 M(-10.0%) | $1.16 B(+2.6%) |
| Dec 1988 | - | $284.94 M(-1.1%) | $1.13 B(+4.3%) |
| Sept 1988 | - | $288.18 M(-11.6%) | $1.08 B(+3.5%) |
| June 1988 | $1.02 B(+31.0%) | $325.99 M(+43.7%) | $1.04 B(+10.2%) |
| Mar 1988 | - | $226.85 M(-4.8%) | $947.03 M(+1.4%) |
| Dec 1987 | - | $238.18 M(-5.5%) | $933.59 M(+7.6%) |
| Sept 1987 | - | $252.17 M(+9.7%) | $868.04 M(+8.6%) |
| June 1987 | $777.81 M(+35.0%) | $229.83 M(+7.7%) | $799.51 M(+14.0%) |
| Mar 1987 | - | $213.41 M(+23.6%) | $701.22 M(+9.6%) |
| Dec 1986 | - | $172.64 M(-6.0%) | $639.66 M(+3.1%) |
| Sept 1986 | - | $183.63 M(+39.6%) | $620.56 M(+5.5%) |
| June 1986 | $576.08 M | $131.55 M(-13.4%) | $588.32 M(+28.8%) |
| Mar 1986 | - | $151.84 M(-1.1%) | $456.77 M(+49.8%) |
| Dec 1985 | - | $153.54 M(+1.4%) | $304.93 M(+101.4%) |
| Sept 1985 | - | $151.39 M | $151.39 M |
FAQ
- What is GSK annual net profit?
- What is the all time high annual net income for GSK?
- What is GSK annual net income year-on-year change?
- What is GSK quarterly net profit?
- What is the all time high quarterly net income for GSK?
- What is GSK quarterly net income year-on-year change?
- What is GSK TTM net profit?
- What is the all time high TTM net income for GSK?
- What is GSK TTM net income year-on-year change?
What is GSK annual net profit?
The current annual net income of GSK is $6.13 B
What is the all time high annual net income for GSK?
GSK all-time high annual net profit is $18.52 B
What is GSK annual net income year-on-year change?
Over the past year, GSK annual net profit has changed by -$12.39 B (-66.89%)
What is GSK quarterly net profit?
The current quarterly net income of GSK is -$75.47 M
What is the all time high quarterly net income for GSK?
GSK all-time high quarterly net profit is $12.74 B
What is GSK quarterly net income year-on-year change?
Over the past year, GSK quarterly net profit has changed by -$510.16 M (-117.36%)
What is GSK TTM net profit?
The current TTM net income of GSK is $3.17 B
What is the all time high TTM net income for GSK?
GSK all-time high TTM net profit is $18.34 B
What is GSK TTM net income year-on-year change?
Over the past year, GSK TTM net profit has changed by -$2.97 B (-48.37%)